Corticotropin-induced reduction of plasma lipoprotein(a) concentrations in healthy individuals and hemodialysis patients: Relation to apolipoprotein(a) size polymorphism

Metabolism: Clinical and Experimental

Volumn 48, Issue 3, 1999, Pages 342-346

  Arnadottir, Margret ^a   Berg, Anna Lena ^b   Kronenberg, Florian ^b   Lingenhel, Arno ^b   Hugosson, Therése ^b   Hegbrant, Jörgen ^b   Nilsson Ehle, Peter ^b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; CORTICOTROPIN; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; PLASMINOGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; FEMALE; GENETIC POLYMORPHISM; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KRINGLE DOMAIN; LIPOPROTEIN BLOOD LEVEL; MALE; PHENOTYPE; PRIORITY JOURNAL;

EID: 0032969218     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90083-5     Document Type: Article

References (27)

1. Rader DJ, Hoeg JM, Brewer HB Jr: Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Ann Intern Med 120:1012-1025, 1994
2. Kronenberg F, Steinmetz A, Kostner GM, et al: Lipoprotein(a) in health and disease. Grit Rev Clin Lab Sci 33:495-543, 1996
3. Wild SH, Fortmann SP, Marcovina SM: A prospective casecontrol study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants. Arterioscler Thromb Vasc Biol 17:239-245, 1997
4. Kronenberg F, Utermann G, Dieplinger H: Lipoprotein(a) in renal disease. Am J Kidney Dis 27:1-25, 1996
5. Utermann G: The mysteries of lipoprotein (a). Science 426:904-910, 1989
6. McLean JW, Tomlinson JE, Kuang WJ, et al: cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 300:132-137, 1987
7. Utermann G, Menzel HJ, Kraft HG, et al: Lp(a) glycoprotein phenotypes: Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 80:458-465, 1987
8. Lackner C, Boerwinkle E, Leffert CC, et al: Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest 87:2153-2161, 1991
9. Kraft HG, Köchl S, Menzel HJ, et al: The apolipoprotein (a) gene: A transcribed hypervariable locus controlling plasma lipoprotein (a) concentration. Hum Genet 90:220-230, 1992
10. Boerwinkle E, Leffert CC, Lin J, et al: Apolipoprotein (a) gene accounts for greater than 90% of the variation in plasma lipoprotein (a) concentrations. J Clin Invest 90:52-60, 1992
11. Berg A-L, Nilsson-Ehle P: Direct effects of ACTH on plasma lipoprotein metabolism in man: Studies in vivo and in vitro. Metabolism 43:90-97, 1994
12. Berg A-L, Nilsson-Ehle P: ACTH lowers serum lipids in steroid treated hyperlipidemic patients with kidney disease. Kidney Int 50:538-542, 1996
13. Arnadottir M, Berg AL, Dallongeville J, et al: Adrenocorticotrophic hormone lowers serum Lp(a) and LDL cholesterol concentrations but does not influence triglyceride metabolism in hemodialysis patients. Kidney Int 52:1651-1655, 1997
14. Kronenberg F, Lobentanz E-M, König P, et al: Effect of sample storage on the measurements of lipoprotein (a), apolipoproteins B and A-IV, total and high-density lipoprotein cholesterol and triglycerides. J Lipid Res 35:1318-1328, 1994
15. Kraft HG, Lingenhel A, Bader G, et al: The relative electrophoretic mobility of apo(a) isoforms depends on the gel system: Proposal of a nomenclature for apo(a) phenotypes. Atherosclerosis 125:53-61, 1996
16. Pedersen RC, Brownie AC: The mechanism of action of adrenocorticotrophic hormone on cholesterol metabolism in the adrenal cortex, in Litwack G (ed): Biochemical Actions of Hormones, vol 21. New York, NY, Academic, 1986, pp 129-166
17. Berg AL, Nilsson-Ehle P: Regulation of hepatic lipase secretion from Hep G2 cells by ACTH and corticosteroids. Horm Metab Res 29:475-476, 1997
18. Bartens W, Krämer-Guth A, Wanner C: Corticotropin increases the receptor-specific uptake of native low-density lipoprotein (LDL) - but not oxidized LDL and native or oxidized lipoprotein(a) [Lp(a)] - in HEPG2 cells: No evidence for Lp(a) catabolism via the LDL receptor. Metabolism 46:726-729, 1997
19. Arnadottir M, Thysell H, Nilsson-Ehle P: Serum concentration of Lp(a) is increased in moderate renal failure. Nephron 72:712-713, 1996
20. Kronenberg F, König P, Neyer U, et al: Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 6:110-120, 1995
21. Dieplinger H, Lackner C, Kronenberg F, et al: Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). J Clin Invest 91:397-401, 1993
22. Kronenberg F, König P, Lhotta K, et al: Apolipoprotein(a) phenotype associated decrease in lipoprotein(a) plasma concentrations after renal transplantation. Arterioscler Thromb 14:1399-1404, 1994
23. Kronenberg F, Trenkwalder E, Lingenhel A, et al: Renovascular arteriovenous differences in Lp(a) plasma concentrations suggest removal of Lp(a) from the renal circulation. J Lipid Res 38:1755-1763, 1997
24. Krempler F, Kostner GM, Bolzano K, et al: Turnover of lipoprotein(a) in man. J Clin Invest 65:1483-1490, 1980
25. Rader DJ, Cain W, Zech LA, et al: Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein(a) isoform is determined by the rate of lipoprotein(a) production. J Clin Invest 91:443-447, 1993
26. Tuck CH, Holleran S, Berglund L: Hormonal regulation of lipoprotein(a) levels: Effects of estrogen replacement therapy on lipoprotein (a) and acute phase reactants in postmenopausal women. Arterioscler Thromb Vasc Biol 9:1822-1829, 1997
27. Crook D, Sidhu M, Seed M, et al: Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid. Atherosclerosis 92:41-47, 1992